Novartis and Roche's big-selling eye drug Lucentis has its first biosimilar competitor in Europe, after the European Commission approved Samsung Bioepis' copycat drug Byooviz. Byooviz (ranibizumab ...

Provident Financial Services, Inc. operates as the bank holding company for Provident Bank that provides various banking products and services to individuals, families, and businesses in the ...

Lucentis was first approved in the US in 2007 for wet AMD and grew quickly thereafter thanks to a string of additional indications, including DMO, myopic choroidal neovascularisation (mCNV) and ...

The differences between PFSs and MDVs (per 1000 doses) is 324.21. MDV: Multidose vial; NA: Not available; PFS: Prefilled syringe. Prefilled syringes (PFSs) have gained market share in the USA ...

consistent safetyONS-5010 demonstrated to be non-inferior to Lucentis at 4 and 12 weeksCompany on track for anticipated BLA resubmission in calendar Q1 2025 ISELIN, N.J., Jan. 23, 2025 (GLOBE ...

The JanSan, foodservice and packaging supplies distributor announced Dec. 4 that it has acquired PFS Sales Company, a foodservice disposables and cleaning supplies distributor servicing the catering, ...

1 Day PFS -2.95% DJIA -1.79% S&P Mid Cap 400 -1.58% Financial Services -1.71% ...

65 First-generation (eg, gefitinib and erlotinib) and second-generation (eg, afatinib and dacomitinib) EGFR TKIs have significantly improved PFS, and overall survival in the case of dacomitinib, ...

Mineral exploration, Mineral processing technological evaluations, Mining and associated infrastructure feasibility evaluations, rare earth offtake structuring and negotiations, progressing ...